Harnessing chitosan and poly-(γ-glutamic acid)-based biomaterials towards cancer immunotherapy
Cancer-related immunosuppression is one of the most challenging aspects of cancer therapy, being one of the principal causes of disease relapse. Most recent immunotherapeutic strategies have been at the forefront of therapies to overcome this problem through targeting T cell-related pathways. Notwit...
Main Authors: | Beatriz V. Lima, Maria J. Oliveira, Mário A. Barbosa, Raquel M. Gonçalves, Flávia Castro |
---|---|
Format: | Article |
Sprog: | English |
Udgivet: |
Elsevier
2022-08-01
|
Serier: | Materials Today Advances |
Fag: | |
Online adgang: | http://www.sciencedirect.com/science/article/pii/S2590049822000480 |
Lignende værker
-
Nanoparticles as Smart Carriers for Enhanced Cancer Immunotherapy
af: Neelam Thakur, et al.
Udgivet: (2020-12-01) -
Designing and Immunomodulating Multiresponsive Nanomaterial for Cancer Theranostics
af: Amreen Khan, et al.
Udgivet: (2021-01-01) -
Nanomedicine-based adjuvant therapy: a promising solution for lung cancer
af: Yiming Xu, et al.
Udgivet: (2023-07-01) -
Terapia adjuvantă cu imunomodulatori în oncologie
af: Ioana Chiţescu, et al.
Udgivet: (2023-12-01) -
Glycol Chitosan-Based Fluorescent Theranostic Nanoagents for Cancer Therapy
af: Jin-Kyu Rhee, et al.
Udgivet: (2014-12-01)